Heart Disease News and Research

Latest Heart Disease News and Research

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

Chronic Obstructive Pulmonary Disease (COPD) is a major cause for hospital stays and emergency room visits across Canada and researchers say minimizing exacerbations or flare-ups of the disease can go a long way to reducing hospitalizations.

25 Mar 2011

Merck to return rights for betrixaban to Portola

Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.

25 Mar 2011

Non-invasive brain stimulation improves swallowing ability among stroke survivors

Stroke patients who received electrical brain stimulation coupled with swallowing exercises showed greater improvement in swallowing ability than patients who did not receive this stimulation, according to a pilot study reported in Stroke: Journal of the American Heart Association.

25 Mar 2011

Study: High intake of omega-3 fats can help prevent obesity-related chronic diseases

A study of Yup'ik Eskimos in Alaska, who on average consume 20 times more omega-3 fats from fish than people in the lower 48 states, suggests that a high intake of these fats helps prevent obesity-related chronic diseases such as diabetes and heart disease.

25 Mar 2011

First AngelMed Guardian cardiac monitor system implanted in patient at Jersey Shore

Today at Jersey Shore University Medical Center, 66-year-old heart attack survivor Charles Theodora from Ocean Township became the first NY/NJ Metropolitan resident to be implanted with the experimental AngelMed Guardian cardiac monitor and alert system device that could alert him if a heart attack is imminent.

25 Mar 2011

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.

25 Mar 2011

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that its specially formulated ischemic adult allogeneic mesenchymal stem cells have been successfully used to treat the first patient in an ischemic stroke study conducted at the University of California, San Diego.

25 Mar 2011

DMC launches new procedure to protect diabetic patients with PAD from leg amputations

The Detroit Medical Center Cardiovascular Institute has implemented a ground-breaking new medical technology designed to protect patients with diabetes-related arterial disease from the risk of foot or leg amputation.

25 Mar 2011

State roundup: Vt. closer to single payer plan

After a full day and evening of debate, the Vermont House gave preliminary approval to health care reform legislation that's designed to put the state on the path toward a single payer system. ... The heart of the bill is the creation of a five person Health Care Board, modeled after the Public Service Board, which will oversee virtually every aspect of health care in the state.

25 Mar 2011

Study finds risk of heart attack among patients with TIA

Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the general population, according to research reported in Stroke: Journal of the American Heart Association.

25 Mar 2011

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.

25 Mar 2011

Positive top-line results from POZEN's PA32540 Phase 1 study against cardiovascular disease

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today positive top-line results of a Phase 1 study of PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin and immediate-release omeprazole.

25 Mar 2011

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Medtronic, Inc. today announced that the U.S. Food & Drug Administration has approved its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems.

25 Mar 2011

Young adults with religious involvement more likely to become obese in middle-age

Could it be the potato salad? Young adults who frequently attend religious activities are 50 percent more likely to become obese by middle age as young adults with no religious involvement, according to new Northwestern Medicine research.

25 Mar 2011

HDL, BG Medicine to offer galectin-3 testing services for patients with heart failure

Health Diagnostic Laboratory, Inc. and BG Medicine, Inc., announced today an agreement under which HDL, Inc. will offer galectin-3 testing services based on the BG Medicine Galectin-3 Test.

25 Mar 2011

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor, a cholesterol-lowering drug, can prevent new colon tumors from forming after colon cancer surgery.

25 Mar 2011

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

AltheRx Inc., a privately-held clinical development company, announced today that it has purchased all assets related to Solabegron from GlaxoSmithKline. Solabegron is a highly selective and potent beta3-adrenoceptor agonist that has demonstrated positive results in Phase II clinical programs for the treatment of Overactive Bladder in women and Irritable Bowel Syndrome.

25 Mar 2011

Sitagliptin drug can slow onset of diabetes

Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.

25 Mar 2011

Mercury in fish may not increase heart disease risk: Study

According to a new study Americans' level of exposure to mercury from sources such as fish is not associated with a higher risk of heart disease, stroke or other cardiovascular disease. This is in spite of the repeated proofs of neurological deficits in children and unborn babies due to mercury exposure.

24 Mar 2011

Religious people more prone to obesity: Study explores link

A new study has shown that people who frequently attend religious services are significantly more likely to become obese by the time they reach middle age. The finding is surprising especially considering that religious people tend to be in better health than others, said study author Matthew J. Feinstein, a medical student at Northwestern University in Chicago. Feinstein said, “It highlights a particular group that appears to be at a greater risk of becoming obese and remaining obese…It's a group that may benefit from targeted anti-obesity interventions and from obesity prevention programs.”

24 Mar 2011

Heart Disease News and Research

Latest Heart Disease News and Research

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

Merck to return rights for betrixaban to Portola

Non-invasive brain stimulation improves swallowing ability among stroke survivors

Study: High intake of omega-3 fats can help prevent obesity-related chronic diseases

First AngelMed Guardian cardiac monitor system implanted in patient at Jersey Shore

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

Stemedica begins allogeneic mesenchymal stem cell Phase I/II trial in patients with ischemic stroke

DMC launches new procedure to protect diabetic patients with PAD from leg amputations

State roundup: Vt. closer to single payer plan

Study finds risk of heart attack among patients with TIA

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Positive top-line results from POZEN's PA32540 Phase 1 study against cardiovascular disease

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Young adults with religious involvement more likely to become obese in middle-age

HDL, BG Medicine to offer galectin-3 testing services for patients with heart failure

Clinical trial to determine whether Crestor can prevent new colon tumors after surgery

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

Sitagliptin drug can slow onset of diabetes

Mercury in fish may not increase heart disease risk: Study

Religious people more prone to obesity: Study explores link

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in